Banco Bilbao Vizcaya Argentaria S.A (BOY)
XETRA Stock Exchange · Germany · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 22.28 |
|---|---|
| 52-week range | 16.79 – 25.51 |
| Return, 1 month / 3 months | −9.2% / −1.5% |
| Return, 1 year / 3 years | +40.2% / +250.6% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 36 |
| Volatility (1 year) | 29.7% |
| Worst drawdown (1 year) | -18.7% |
| Average daily value traded | 0.16M EUR |
| Dividend yield | 5.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Banco Bilbao Vizcaya Argentaria, known as BBVA, is a Spanish banking group based in Madrid. It offers retail and commercial banking, savings and current accounts, mortgages, consumer loans, credit cards, insurance and asset management. Its customers include individual households, small businesses, companies and institutional clients. The group serves customers in Spain and other European countries, in the Americas and in Turkey, through branch networks and digital banking services.
On this site Banco Bilbao Vizcaya Argentaria S.A appears as a stock on the XETRA Stock Exchange (Germany), code BOY, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Banco Bilbao Vizcaya Argentaria S.A (BOY) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 22.28 on 22 October 2026.
Its price-based Market X-Ray is 71 out of 100 (a strong price profile), ranking 90 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 40.2% and over the last three months it fell 1.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 77 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 6.4% | ||
| From 52-week high | -12.3% | ||
| Momentum | 75 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | -1.5% | ||
| 6-month return | 18.7% | ||
| 12-month return, skipping the last month | 54.4% | ||
| Stability (higher is calmer) | 74 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 29.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.7% | ||
| Liquidity | 50 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.16M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 69 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.8% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −4.2% |
|---|---|
| 1 month | −9.2% |
| 3 months | −1.5% |
| 6 months | +18.7% |
| 1 year | +40.2% |
| 3 years | +250.6% |
| 5 years | +434.9% |
Signals
| 50-day / 200-day average | 24.13 / 20.94 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.51 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Oct 2026 | EUR 0.3700 |
| 8 Apr 2026 | EUR 0.6000 |
| 5 Nov 2025 | EUR 0.3200 |
| 8 Apr 2025 | EUR 0.4100 |
| 8 Oct 2024 | EUR 0.2900 |
| 8 Apr 2024 | EUR 0.3900 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.